Fair Value Calculator Fair Value Calculator
EN DE

2310 (2310) Fair Value & Analysis

Consumer Cyclical · Market cap HK$155M

2 2310 2310 · HK
PriceHK$0.1420
Fair ValueHK$0.0400
Upside-71.8%
Quality56/100
Watch 2310 for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range HK$0.0400 – HK$0.0400

Fair value as of: Jul 2, 2026

From 5 valuation models · updated today

Share price −35.5% over the past month.

Price vs Fair Value (12 months)

HK$0.2360 HK$0.0280 Fair Value HK$0.0400 Jun 2025 Jul 2026

12‑month range HK$0.0280 – HK$0.2360 · the HK$0.1420 price screens above the HK$0.0400 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2310 (2310) currently trades at HK$0.1420, while our model-based Fair Value estimate is HK$0.0400 — implying the stock looks roughly 71.8% overvalued today. We read business quality at 56/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 2310 generated revenue of HK$117M at a net margin of -1.2%. Revenue grew 6.6% year over year. Net debt stands at HK$80.7M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$117M
Revenue growth (YoY) +6.6%
Net margin -1.2%
Return on equity -3,435%
Free cash flow −HK$1.0M FY2025
Operating margin 3.9%
More key figures
Net debt HK$80.7M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2310 reported revenue of HK$117M in FY2025 versus HK$77.7M in FY2021, a compound +10.8%/yr. Reported net income was −HK$1.4M in FY2025.

Revenue +10.8%/yr
FY21 HK$77.7M
FY22 HK$96.1M
FY23 HK$102M
FY24 HK$111M
FY25 HK$117M
Net income
FY21 −HK$20.9M
FY22 −HK$24.2M
FY23 −HK$8.3M
FY24 −HK$7.5M
FY25 −HK$1.4M

Is 2310 fairly valued? → Check now

Similar stocks

6 more Resorts & Casinos stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Las Vegas Sands Corp LVS $50.81 $54.02 +6%
Galaxy Entertainment Group GXYEF $4.10 $5.06 +23%
0027 0027 HK$29.42 HK$41.44 +41%
Sands China Ltd SCHYF $1.70 $2.18 +28%
MGM Resorts International, through its subsidiaries, MGM $46.57 $17.73 -62%
Wynn Resorts, Limited WYNN $103.62 $90.24 -13%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 2310 (2310) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0400 versus a price of HK$0.1420 — about −72% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 2310?
Our model-based fair value for 2310 is HK$0.0400 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1420.
What is the quality score of 2310?
2310 has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 2310 (2310)?
2310 reported trailing-twelve-month revenue of about HK$117M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 2310?
The net profit margin of 2310 is about -1.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.